Blood

Vol. 146, Issue Supplement 1 Issue Supplement 1 2025
8248
Articles

Articles in this Issue

Comprehensive genomic profiling refines diagnosis and reveals actionable fusions in myeloid malignancies: A real-world analysis

John M. Furgason, Timothy J. Stuhlmiller, Madhuri Paul et al. Nov 03, 2025 pp. 6410-6410 10.1182/blood-2025-6410

Abstract Background: Real-world data (RWD) provide essential insights into diagnostic and treatment patterns for myeloid...

Evaluating efficacy and safety of hydroxyurea and thalidomide for beta-thalassemia: A systematic review andmeta-analysis.

Maheen Imran Shaikh, Mehak Gul, Syed Maaz et al. Nov 03, 2025 pp. 6473-6473 10.1182/blood-2025-6473

Abstract INTRODUCTION Therapeutic interventions such as hydroxyurea and thalidomide have individually demonstrated a reduction in transfusio...

Engineered iPSC-derived NK cells targeting the SIGLEC7-glyco-immune checkpoint improves anti-tumor activity in solid cancers

Jaya Lakshmi Thangaraj, Edith Lopez, Kevin Tharp et al. Nov 03, 2025 pp. 5913-5913 10.1182/blood-2025-5913

Abstract Sialylated glycans are typically over-expressed on the surface of tumor cells compared to normal cells. These glycans engage inhibi...

Prognostic impact of Mantle Cell Lymphoma frontline induction response assessments in the ECOG-ACRIN E1411 study of bendamustine-rituximab +/- bortezomib and maintenance with rituximab +/- lenalidomide

Christine Ryan, Victoria Wang, Mitchell Smith et al. Nov 03, 2025 pp. 3581-3581 10.1182/blood-2025-3581

Abstract Background The prognostic utility of positron emission tomography/computer tomography (PET/CT) scan and bone marrow biopsy (BMB) as...

5-azacytidine treatment reshapes clonal structure and alters mutation-dependent splicing in MDS patients

Xuan Zhang, Mutian Tang, Guangyuan Li et al. Nov 03, 2025 pp. 2054-2054 10.1182/blood-2025-2054

Abstract Among molecular and cellular hallmarks of aging, changes in genetics, the epigenome and inflammation are now recognized as key medi...

From crisis to cure? thirteen years of real-world trends in acute promyelocytic leukemia outcomes in Qatar

Ghasoub Rola, Hesham Elsabah, Anas Hamad et al. Nov 03, 2025 pp. 6926-6926 10.1182/blood-2025-6926

Abstract Background: Acute promyelocytic leukemia (APL) is a distinct and highly curable subtype of acute myeloid leukemia. Despite the avai...

A high-dimensional spatiotemporal single-cell and 3D atlas of the bone marrow microenvironment during CML progression: Leukemia-driven vascular remodeling, immune dysregulation, and megakaryocyte abnormalities

Lanzhu Li, Isabelle Rottmann, Geoff Ivison et al. Nov 03, 2025 pp. 6774-6774 10.1182/blood-2025-6774

Abstract The bone marrow microenvironment (BMME) critically regulates hematopoiesis and immune function. Disruptions in its cellular composi...

Single-cell transcriptomics reveals proliferative, immune-evasive, and bone marrow–independent transcriptional programs in extramedullary multiple myeloma.

Saurabh Zanwar, Surendra Dasari, Wilson Gonsalves et al. Nov 03, 2025 pp. 3940-3940 10.1182/blood-2025-3940

Abstract Background Extramedullary disease (EMD) in multiple myeloma (MM) represents an aggressive phenotype with poor outcomes. We performed...

Factors associated with acute and chronic graft-versus-host disease after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Moazzam Shahzad, Muhammad Kashif Amin, Amir Kasaeian et al. Nov 03, 2025 pp. 4254-4254 10.1182/blood-2025-4254

Abstract Background: Graft-versus-host disease (GVHD) is a significant complication of allogeneic hematopoietic cell transplantation (allo-H...

Comparative analysis of ide-cel and cilta-cel in patients with Relapsed/Refractory multiple myeloma: A nationwide, retrospective, real-world analysis across Austria

Irene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing et al. Nov 03, 2025 pp. 4584-4584 10.1182/blood-2025-4584

Abstract Background: B-cell maturation antigen–directed CAR-T cells have revolutionized the therapeutic landscape of relapsed/refractory mul...

Combined FLT3 and EZH1/2 inhibition reduces LSCs and promotes myeloid differentiation in PDX models of AML

Murugan Selvam, Marianna Giorgi, Mark Long et al. Nov 03, 2025 pp. 1488-1488 10.1182/blood-2025-1488

Abstract Activating mutations in FMS-like tyrosine kinase 3 (FLT3) are among the most frequently identified mutations in acute myeloid leuke...

Comparative efficacy and safety of bendamustine versus fludarabine and cyclophosphamide as lymphodepleting regimens for CAR-T therapy in hematological malignancies: A systematic review and meta-analysis

Akihiro Miyashita, Magda Sofía Jiménez Castellanos, Thomas Rodgers Nov 03, 2025 pp. 7686-7686 10.1182/blood-2025-7686

Abstract Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy has become an established treatment for acute lymphoblastic leukemia...

Adrenergic signaling and hematopoietic stem cell function in the bone marrow niche rely on peri-arteriolar NADPH oxidase (NOX) and connexin gap junctions.

Francesca LiCausi, Mahamudun Bhuiyan, Randall S. Carpenter et al. Nov 03, 2025 pp. 427-427 10.1182/blood-2025-427

Abstract Hematopoietic stem cell (HSC) activity is tightly regulated by the bone marrow (BM) microenvironment, often referred to as “niche”....

Mass spectrometry compared to serum electrophoresis and immunofixation to detect monoclonal proteins and therapeutic antibodies in plasma cell disorders

Malin Hultcrantz, Shelby Hutcherson, Andriy Derkach et al. Nov 03, 2025 pp. 5793-5793 10.1182/blood-2025-5793

Abstract Background Serum protein electrophoresis (SPEP) and immunofixation (IFE) are the standard methods for detecting and monitoring mono...

Infection rates and mortality in multiple myeloma: Impact of blood counts and IgG levels over time

Neha Puttagunta, Phyu Thin Naing, Alex Luc et al. Nov 03, 2025 pp. 7512-7512 10.1182/blood-2025-7512

Abstract Background Infection is one of the leading causes of mortality in multiple myeloma (MM) due to disease-related...

Real-world pharmacovigilance of BCMA-targeted CAR-T therapy in refractory multiplemyeloma: A comparative analysis of idecabtagene vicleucel and ciltacabtagene autoleucel

Ahmed Mustafa, Nasim Salimiaghdam, Ahmad Iqbal et al. Nov 03, 2025 pp. 4028-4028 10.1182/blood-2025-4028

Abstract Background: B-cell maturation antigen (BCMA)-directed CAR-T therapies have redefined care for relapsed and refractory multiple myelo...

High-throughput single-cell methylation resolves epigenetic states in hematopoietic differentiation and age-related clonal expansions

Alba Rodriguez-Meira, Sander Lambo, Carolina Varona-Arguelles et al. Nov 03, 2025 pp. 977-977 10.1182/blood-2025-977

Abstract DNA methylation at CpG dinucleotides is a critical regulator of cell identity and epigenetic memory, and it becomes universally dis...

Characterization of pityriasis rubra pilaris with hematological malignancies: Paraneoplastic disease and targeted therapy reactions

Ruhi Kanwar, Sarah Schultz, Nancy Anabaraonye et al. Nov 03, 2025 pp. 8104-8104 10.1182/blood-2025-8104

Abstract Pityriasis rubra pilaris (PRP) is a chronic, inflammatory papulosquamous skin condition of poorly understood pathogenesis; fewer th...

Allele-dependent activity of promoters of genes SLC22A4 and SLC22A5 encoding imatinib transporters in chronic myeloid leukemia

Pavel Burda, Nikola Curik, Alzbeta Hlavackova et al. Nov 03, 2025 pp. 3756-3756 10.1182/blood-2025-3756

Abstract Introduction In our previous studies, we identified an association between the regulatory SNP rs460089, located in the promoter of S...

Bayesian diagnostic test accuracy meta-analysis of ¹⁸F-FDG PET/CT for detecting Richter's transformation in chronic lymphocytic leukemia

Hanzala Jehangir, Muhammad Arham, Muhammad Uzair et al. Nov 03, 2025 pp. 7420-7420 10.1182/blood-2025-7420

Abstract Introduction: Richter's transformation (RT) occurs in approximately 8–10% of patients with chronic lymphocytic leukemia (CLL) and i...

Clonal architecture and dynamics of somatic evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria

Michael Spencer Chapman, Kudzai Nyamondo, Nicholas Williams et al. Nov 03, 2025 pp. 25-25 10.1182/blood-2025-25

Abstract Aplastic anemia (AA) is a life-threatening bone marrow failure driven by T-cell attack on hematopoietic stem and progenitor cells (...

Fixed-duration preemptive rituximab maintenance over two years in recurrent thrombotic thrombocytopenic purpura with low ADAMTS13: A single-center case series

Mohamad Khawandanah, Macie Brannum, Honieh Sowdagar et al. Nov 03, 2025 pp. 1338-1338 10.1182/blood-2025-1338

Abstract Introduction: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy (TMA) caused by severely r...

Integrated transcriptomic and proteomic analysis of clonal plasma cells from patients with AL amyloidosis

Ourania Theologi, Ioannis Kollias, Kostantina Taouxi et al. Nov 03, 2025 pp. 3931-3931 10.1182/blood-2025-3931

Abstract Systemic AL amyloidosis is a rare disease caused by the abnormal extracellular deposition of misfolded immunoglobulin light chain f...

Patient experience sub-study of a randomised UK multicentre Phase 2 trial of ASTX727 versus hydroxycarbamide/best supportive care in myelodysplastic (MDS)/myeloproliferative (MPN) overlap syndromes (AMMO)

Ashleigh Ward, Sally Taylor, Grant Punnett et al. Nov 03, 2025 pp. 8164-8164 10.1182/blood-2025-8164

Abstract Introduction MDS/MPN Overlap Syndromes are haematological neoplasms with overlapping features of myeloid dysplasia and proliferatio...

Different graft-vs-host disease prophylaxis strategy for allogeneic hematopoietic stem cell transplantation in adults with chronic active EBV infection

Min Liu, Qiuxia Yu, Yang Cao et al. Nov 03, 2025 pp. 7758-7758 10.1182/blood-2025-7758

Abstract Background: Adult patients with chronic active Epstein-Barr virus (CAEBV) infection face a challenging prognosis. Increasing eviden...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page